Is there a gender difference in the effect of antioxidants on cancer risk?

British Journal of Nutrition

Volumn 94, Issue 2, 2005, Pages 139-140

  Higdon, Jane V ^a   Frei, Balz ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; DNA; LYCOPENE; NUTRACEUTICAL; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SELENIUM; ZINC;

ANTIOXIDANT ACTIVITY; BREAST CANCER; CANCER RISK; CARCINOGENESIS; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; HUMAN; MALE; MINERAL INTAKE; NOTE; NUTRIENT; PROSTATE CANCER; SEX DIFFERENCE; VITAMIN INTAKE;

ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; DIETARY SUPPLEMENTS; DNA DAMAGE; HUMANS; NEOPLASMS; RISK FACTORS; SEX FACTORS; VITAMINS;

EID: 25444469409     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN20051471     Document Type: Note

References (17)

1. Blot WJ, Li JY, Taylor PR, et al. (1993) Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85, 1483-1492.
2. Cook NR, Stampfer MJ, Ma J, Manson JE, Sacks FM, Buring JE & Hennekens CH (1999) β-Carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer 86, 1783-1792.
3. Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, Marshall JR & Clark LC (2003) Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 91, 608-612.
4. Eichholzer M, Stahelin HB, Gey KF, Ludin E & Bernasconi F (1996) Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer 66, 145-150.
5. Galan P, Briançon S, Favier A, et al. (2005) Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels? Br J Nutr 94, 125-132.
6. Heinonen OP, Albanes D, Virtamo J, et al. (1998) Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 90, 440-446.
7. Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norkus EP, Morris JS & Comstock GW (2000) Association between α-tocopherol, γ-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 92, 2018-2023.
8. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A & Briancon S (2004) The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164, 2335-2342.
9. Higdon J & Frei B (2005) Vitamin C, vitamin E, and β-carotene in cancer chemoprevention. In Phytopharmaceuticals in Cancer Chemoprevention, pp. 271-309 [D Bagchi and H Preuss, editors]. Boca Raton, FL: CRC Press.
10. Khaw KT, Bingham S, Welch A, Luben R, Wareham N, Oakes S & Day N (2001) Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition. Lancet 357, 657-663.
11. Loria CM, Klag MJ, Caulfield LE & Whelton PK (2000) Vitamin C status and mortality in US adults. Am J Clin Nutr 72, 139-145.
12. Moller P & Loft S (2004) Interventions with antioxidants and nutrients in relation to oxidative DNA damage and repair. Mutat Res 551, 79-89.
13. Simon JA, Hudes ES & Tice JA (2001) Relation of serum ascorbic acid to mortality among US adults. J Am Coll Nutr 20, 255-263.
14. Tamimi RM, Hankinson SE, Campos H, Spiegelman D, Zhang S, Colditz GA, Willett WC & Hunter DJ (2005) Plasma carotenoids, retinol, and tocopherols and risk of breast cancer. Am J Epidemiol 161, 153-160.
15. Waters DJ, Chiang EC, Cooley DM & Morris JS (2004) Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women. Mutat Res 551, 91-107.
16. Weinstein SJ, Wright ME, Pietinen P, King I, Tan C, Taylor PR, Virtamo J & Albanes D (2005) Serum α-tocopherol and γ-tocopherol in relation to prostate cancer risk in a prospective study. J Natl Cancer Inst 97, 396-399.
17. Woodall AA & Ames BN (1997) Diet and oxidative damage to DNA: the importance of ascorbate as an antioxidant. In Vitamin C in Health and Disease, pp. 193-204 [L Packer and J Fuchs, editors]. New York: Marcel Dekker.